|
ONVO | Vivosim Labs, Inc. |
|
|
ONVO | Vivosim Labs, Inc. |
| Biological Products (no Diagnostic Substances) |
| Book value per $ invested | $ 1.80 |
| Leverage | 27.06% |
| Market Cap | $ 3.9m |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -2.2m |
| Margin | -21.44% |
Organovo Holdings, Inc., a biotechnology company, is focused on developing 3D tissues that recapitulate key aspects of human disease. The company is headquartered in Solana Beach, California.